Michael E. Prevoznik is Senior Vice President, and General Counsel for Quest Diagnostics.
In addition to ensuring that Quest Diagnostics meets all of its legal requirements as a public company, he is also responsible for, security and government affairs. From April 2011 to January 2017, Mr. Prevoznik also had management responsibility for the company’s diagnostic information services activities outside of the U.S., and from April 2011 to January 2013, he had management responsibility for the company’s clinical trials business. From 1999 until April 2009, Mr. Prevoznik also had responsibility for the Company's Compliance Department He was appointed Vice President and General Counsel in 1999, and was named a Senior Vice President in 2003.
Mr. Prevoznik joined Quest Diagnostics in 1999 through the acquisition of SmithKline Beecham Clinical Laboratories (SBCL). He joined SBCL in 1994 as Chief Legal Compliance Officer, and in 1996 was named Vice President and Chief Legal Compliance Officer for SmithKline Beecham Healthcare Services. In 1998, he was appointed Vice President, Compliance, for SmithKline Beecham, a role in which he developed and led the company’s global compliance activities.
Prior to joining SmithKline Beecham, Mr. Prevoznik represented SBCL as outside legal counsel as an Associate with Dechert Price & Rhoads of Philadelphia, where he specialized in healthcare and general corporate law.
Mr. Prevoznik holds a Bachelor of Science degree from the University of Notre Dame, and an M.B.A. from the University of Chicago. He earned his J.D. degree from the University of Pennsylvania Law School.
What is Michael E. Prevoznik's net worth?
The estimated net worth of Michael E. Prevoznik is at least $5.89 million as of February 29th, 2024. Mr. Prevoznik owns 38,478 shares of Quest Diagnostics stock worth more than $5,890,982 as of December 22nd. This net worth evaluation does not reflect any other investments that Mr. Prevoznik may own. Additionally, Mr. Prevoznik receives a salary of $881,230.00 as SVP at Quest Diagnostics. Learn More about Michael E. Prevoznik's net worth.
How old is Michael E. Prevoznik?
What is Michael E. Prevoznik's salary?
As the SVP of Quest Diagnostics Incorporated, Mr. Prevoznik earns $881,230.00 per year. There are 3 executives that earn more than Mr. Prevoznik. The highest earning executive at Quest Diagnostics is Mr. James E. Davis, Chairman, CEO & President, who commands a salary of $2,880,000.00 per year. Learn More on Michael E. Prevoznik's salary.
How do I contact Michael E. Prevoznik?
Has Michael E. Prevoznik been buying or selling shares of Quest Diagnostics?
Michael E. Prevoznik has not been actively trading shares of Quest Diagnostics in the last ninety days. Most recently, Michael E. Prevoznik sold 5,611 shares of the business's stock in a transaction on Thursday, February 29th. The shares were sold at an average price of $125.88, for a transaction totalling $706,312.68. Following the completion of the sale, the senior vice president now directly owns 38,478 shares of the company's stock, valued at $4,843,610.64. Learn More on Michael E. Prevoznik's trading history.
Who are Quest Diagnostics' active insiders?
Quest Diagnostics' insider roster includes Mark Delaney (SVP), Michael Deppe (CAO), Catherine Doherty (SVP), Vicky Gregg (Director), Mark Guinan (CFO), Karthik Kuppusamy (SVP), Michael Prevoznik (SVP), Timothy Ring (Director), Stephen Rusckowski (CEO), Daniel Stanzione (Director), and Gail Wilensky (Director). Learn More on Quest Diagnostics' active insiders.
Are insiders buying or selling shares of Quest Diagnostics?
In the last twelve months, insiders at the medical research company sold shares 10 times. They sold a total of 39,850 shares worth more than $5,692,423.40. The most recent insider tranaction occured on November, 6th when CAO Michael J Deppe sold 18,755 shares worth more than $2,889,207.75. Insiders at Quest Diagnostics own 0.8% of the company.
Learn More about insider trades at Quest Diagnostics. Information on this page was last updated on 11/6/2024.
